+ Follow GIST Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 2141808
[Title] => Philippines wins global science competition
[Summary] => The Philippines won the first-ever Global Innovation through Science and Technology Catalyst Pitch competition given by the US Department of State with its Philippine-based startup Galansiyang, placing first in two categories.
[DatePublished] => 2021-11-17 00:00:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1804865
[AuthorName] => Pia Lee-Brago
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[1] => Array
(
[ArticleID] => 700713
[Title] => Novartis partners with TMC to enhance gastrointestinal stromal tumor mg't
[Summary] => Research-based health care company Novartis has partnered with The Medical City (TMC) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.
[DatePublished] => 2011-06-30 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[2] => Array
(
[ArticleID] => 698526
[Title] => Novartis partners with NKTI to enhance mg't of gastrointestinal stromal tumor
[Summary] => Research-based health care company Novartis has partnered with the National Kidney and Transplant Institute (NKTI) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.
[DatePublished] => 2011-06-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 464588
[Title] => Reducing risk of cancer returning in patients
[Summary] => MANILA, Philippines – Data published in the online edition of the Lancet show that imatinib, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal tumors (GIST) compared with placebo.
[DatePublished] => 2009-05-07 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
GIST
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 2141808
[Title] => Philippines wins global science competition
[Summary] => The Philippines won the first-ever Global Innovation through Science and Technology Catalyst Pitch competition given by the US Department of State with its Philippine-based startup Galansiyang, placing first in two categories.
[DatePublished] => 2021-11-17 00:00:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1804865
[AuthorName] => Pia Lee-Brago
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[1] => Array
(
[ArticleID] => 700713
[Title] => Novartis partners with TMC to enhance gastrointestinal stromal tumor mg't
[Summary] => Research-based health care company Novartis has partnered with The Medical City (TMC) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.
[DatePublished] => 2011-06-30 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[2] => Array
(
[ArticleID] => 698526
[Title] => Novartis partners with NKTI to enhance mg't of gastrointestinal stromal tumor
[Summary] => Research-based health care company Novartis has partnered with the National Kidney and Transplant Institute (NKTI) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.
[DatePublished] => 2011-06-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 464588
[Title] => Reducing risk of cancer returning in patients
[Summary] => MANILA, Philippines – Data published in the online edition of the Lancet show that imatinib, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal tumors (GIST) compared with placebo.
[DatePublished] => 2009-05-07 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
